Listen free for 30 days

Listen with offer

Get this deal Try for £0.00
Offer ends May 1st, 2024 11:59PM GMT. Terms and conditions apply.
£7.99/month after 3 months. Renews automatically.
Pick 1 audiobook a month from our unmatched collection - including bestsellers and new releases.
Listen all you want to thousands of included audiobooks, Originals, celeb exclusives, and podcasts.
Access exclusive sales and deals.
£7.99/month after 30 days. Renews automatically. See here for eligibility.
Pick 1 audiobook a month from our unmatched collection - including bestsellers and new releases.
Listen all you want to thousands of included audiobooks, Originals, celeb exclusives, and podcasts.
Access exclusive sales and deals.
先端医療ベンチャー(週刊東洋経済ｅビジネス新書Ｎo.309) cover art

先端医療ベンチャー(週刊東洋経済ｅビジネス新書Ｎo.309)

By: 週刊東洋経済編集部
Narrated by: 海老塚 久蔵
Get this deal Try for £0.00

Pay £99p/month. After 3 months pay £7.99/month. Renews automatically. See terms for eligibility.

£7.99/month after 30 days. Renews automatically. See here for eligibility.

Buy Now for £5.19

Buy Now for £5.19

Pay using card ending in
Switch payment method
By completing your purchase, you agree to Audible's Conditions of Use and authorise Audible to charge your designated card or any other card on file. Please see our Privacy Notice, Cookies Notice and Interest-based Ads Notice.

Summary

世界の投資家たちが医療ベンチャーに熱い視線を送っている。
２０１８年、世界のベンチャーキャピタルによるバイオテクノロジー分野への投資額は約１・７兆円に達し、１０年で７倍近くに膨らんだ。ゲノム解読費用が急減し、ビッグデータの活用で、患者一人ひとりに合わせた医療を提供する「プレシジョン・メディシン」の到来だ。製薬業界でもバイオベンチャーが開発した遺伝子治療薬やウイルス製剤などが希少疾患で成果を上げ、Ｍ＆Ａや提携も活発化している。次世代における医療の覇者は誰か。最先端ベンチャーを通して、未来をのぞく。

本誌は『週刊東洋経済』２０１９年４月２０日号掲載の２６ページ分を電子化したものです。
©東洋経済新報社 (P)2020 Audible, Inc.
Marketing
Show More Show Less

What listeners say about 先端医療ベンチャー(週刊東洋経済ｅビジネス新書Ｎo.309)

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.co.uk reviews

Amazon reviews
No Reviews are Available